Results 121 to 130 of about 90,842 (160)
Some of the next articles are maybe not open access.
Chemoprevention of squamous cell carcinoma of the head and neck
Current Opinion in Oncology, 2007The aim of this article is to summarize progress in understanding of the biology of squamous cell carcinoma of the head and neck and of trials to prevent malignant conversion of oral premalignant lesions and the development of second primary tumors in those already treated for squamous cell carcinoma of the head and neck.The understanding of squamous ...
John M, Wrangle, Fadlo R, Khuri
openaire +2 more sources
Basaloid squamous cell carcinoma of the head and neck
Current Opinion in Otolaryngology & Head and Neck Surgery, 2004Basaloid squamous cell carcinoma is an uncommon variant of squamous cell carcinoma and was first described as a distinct entity in 1986. Basaloid squamous cell carcinoma seems to have a poorer survival rate than classical squamous cell carcinoma. On the basis of a critical literature survey, we attempt to evaluate if basaloid squamous cell carcinoma is
Zbären P, Nuyens M, Stauffer E
openaire +3 more sources
Angiogenesis in head and neck squamous cell carcinoma
Clinical Otolaryngology and Allied Sciences, 2000Tumour angiogenesis has recently attracted a great deal of attention as a critical part of oncogenesis and a necessary prerequisite for a malignant phenotype. Research into this process not only offers new insights into tumour biology but is also leading to the development of realistic novel and minimally toxic anti-tumour therapies.
J J, Homer, J, Greenman, N D, Stafford
openaire +2 more sources
Head and neck squamous cell carcinoma in childhood
Medical and Pediatric Oncology, 1998Squamous cell carcinoma (SCC) of the head and neck region is rare in young patients and even less frequent in children 15 years or younger children. The patients reported in the literature are isolated cases and their management is always difficult because there is no large experience or a convincing theory to support treatment decisions for every ...
M B, de Carvalho +10 more
openaire +2 more sources
Cetuximab In Squamous Cell Carcinoma of the Head and Neck
Future Oncology, 2006Surgery and radiotherapy are the standard treatment options for patients with squamous cell carcinoma of the head and neck (SCCHN). Chemotherapy and chemoradiotherapy are new alternatives for locally advanced disease, particularly induction chemotherapy for patients with unresectable tumors.
Ricardo, Hitt +2 more
openaire +2 more sources
The economics of squamous cell carcinoma of the head and neck
Current Opinion in Otolaryngology & Head & Neck Surgery, 2007The current review presents a brief overview of the recent literature on the costs of squamous cell carcinoma of the head and neck (SCCHN), one of the most common forms of cancer. SCCHN is a relatively deadly disease. Approximately 50% of patients survive to 5 years, and surgery and chemoradiotherapy can leave survivors with pain, disfigurement, and ...
Joseph, Menzin +2 more
openaire +2 more sources
Pharmacotherapy of head and neck squamous cell carcinoma
Expert Opinion on Pharmacotherapy, 2009The clinical management of locally advanced head and neck squamous cell carcinoma (HNSCC) is a challenging problem and requires a multidisciplinary approach. Historically, locally advanced HNSCC has been primarily managed with surgery and radiation (RT).
Quintin, Pan +2 more
openaire +2 more sources
Pharmacotherapy for squamous-cell carcinoma of the head and neck
Expert Opinion on Pharmacotherapy, 2011squamous-cell carcinoma of the head and neck (HNSCC) is one of the most common malignancies, the treatment of which constitutes a therapeutic challenge.the purpose of this review is to provide an update on the pharmacotherapy for the treatment of HNSCC focusing mainly on molecular-targeted therapies.
Giorgos, Papaspyrou +2 more
openaire +2 more sources
Stem cells in head and neck squamous cell carcinoma
British Journal of Oral and Maxillofacial Surgery, 2011The existence of a small subpopulation of tumourigenic cancer stem cells in the bulk of human head and neck squamous cancers (SCC) has been recognised in recent reports. This subpopulation has self-renewal properties and is responsible for the production of differentiated daughter cells that form the bulk of the tumour.
Kaveh, Shakib +2 more
openaire +2 more sources
Head and neck squamous cell carcinoma: Better to be young
Otolaryngology - Head and Neck Surgery, 1997Most head and neck squamous cell carcinoma patients are elderly, with few younger than 40 years. Controversy exists in the literature regarding outcomes for younger patients. The goal of this research project was to compare baseline features and outcomes for young patients (≤40 years), middle‐aged patients (41‐64 years), and old patients (≥65 years ...
P D, Lacy +3 more
openaire +2 more sources